EXCLUSIVE WEBINAR | Guidelines for the Management of Non-Transfusion Dependent β-Thalassaemia
On February 2, 2024, we invite you to join us for an exclusive webinar focusing on the ‘Guidelines for the Management of Non-Transfusion Dependent β-Thalassaemia (NTDT)’. Gain valuable insights into one of TIF’s latest and highly popular publications and be part of this must-attend event!
📌 Webinar Title: Guidelines for the Management of Non-Transfusion Dependent β-Thalassaemia
📌 Date & Time: Friday, February 02, 2024, 15:00 CET
Recognizing the Clinical Relevance of NTDT
Non‐transfusion‐dependent thalassaemias (NTDT) encompass a spectrum of anaemias rarely requiring blood transfusions. These clinical phenotypes lie between thalassaemia minor and major, with considerable overlap among the conditions.
The updated edition of NTDT guidelines stands as a critical contribution by TIF to improve patient care for NTDT—a field that has been historically undervalued in terms of importance and clinical relevance. For too long, healthcare professionals regarded NTDT as less urgent when it came to early diagnosis or specialized monitoring and management.
In recent times, significant progress has been made in understanding NTDT and its associated complications. This has led to the development of novel therapies based on our evolving understanding of the disease.
These remarkable advancements have also revealed new challenges that need addressing. By refining management practices, we can implement proactive strategies for the prevention, anticipation, and treatment of morbidities related to health and quality of life for those affected by NTDT.
Download the NTDT Guidelines
The Webinar
In our exclusive webinar, international experts and authors of the publication, Prof. Ali Taher (Professor of Internal Medicine, Hematology Oncology; Director, Naef K. Basile Cancer Institute; Vice Chair Research, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon), Prof. Maria D. Cappellini (Professor of Medicine, Department of Clinical Sciences and Community, University of Milan; IRCCS Ca’ Granda Foundation Maggiore Policlinico Hospital, Milan, Italy), and Dr. Khaled Musallam (Group Chief Research Officer, VPS Healthcare, Abu Dhabi, UAE; President, International Network of Haematology, London, UK) will share their in-depth knowledge on NTDT clinical management techniques and invaluable insights.
Join us to gain essential understanding and engage in stimulating discussions on the most effective approaches to NTDT care!
